You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sleep specialists

Showing 1 - 25 of 9,554
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Pain Trial (Standard pain management combined with sleep disorder management)

Not yet recruiting
  • Chronic Pain
  • Standard pain management combined with sleep disorder management
  • (no location specified)
Sep 25, 2023

Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy Trial in United States (mazindol extended release, Placebo)

Completed
  • Narcolepsy
  • +2 more
  • mazindol extended release
  • Placebo
  • Birmingham, Alabama
  • +21 more
Aug 11, 2022

Narcolepsy With Cataplexy, Narcolepsy, Narcolepsy Without Cataplexy Trial in United States (Mazindol)

Enrolling by invitation
  • Narcolepsy With Cataplexy
  • +2 more
  • Birmingham, Alabama
  • +21 more
Jun 1, 2022

OSA - Obstructive Sleep Apnea Trial in United States (AD109, AD504, Atomoxetine Hydrochloride)

Completed
  • OSA - Obstructive Sleep Apnea
  • Los Angeles, California
  • +24 more
Dec 5, 2022

Obstructive Sleep Apnea, OSA, Apnea Trial in United States (Hypoglossal Nerve Stimulation)

Recruiting
  • Obstructive Sleep Apnea
  • +6 more
  • Hypoglossal Nerve Stimulation
  • Birmingham, Alabama
  • +19 more
Aug 21, 2022

Idiopathic Hypersomnia Trial in United States (Pitolisant Oral Tablet, Placebo oral tablet)

Recruiting
  • Idiopathic Hypersomnia
  • Pitolisant Oral Tablet
  • Placebo oral tablet
  • Scottsdale, Arizona
  • +50 more
Jun 14, 2022

Sleep Apnea, Obstructive, Sleep Apnea, Central Trial in United States (DreamKit)

Completed
  • Sleep Apnea, Obstructive
  • Sleep Apnea, Central
  • DreamKit
  • Birmingham, Alabama
  • +6 more
Mar 1, 2022

Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)

Enrolling by invitation
  • Idiopathic Hypersomnia
  • Excessive Daytime Sleepiness
  • Peoria, Arizona
  • +57 more
Nov 10, 2022

Narcolepsy Trial in Canada, United States (SUVN-G3031, Placebo)

Recruiting
  • Narcolepsy
  • Birmingham, Alabama
  • +40 more
Sep 9, 2022

Chronic Pain, Appetite Disorders, Neuropathy Trial in United States

Recruiting
  • Chronic Pain
  • +6 more
    • Los Gatos, California
    • +3 more
    Jul 15, 2022

    Restless Legs Syndrome Trial in Menlo Park, San Ramon (NTX100 Neuromodulation System - Active, NTX100 Neuromodulation System -

    Recruiting
    • Restless Legs Syndrome
    • NTX100 Neuromodulation System - Active
    • NTX100 Neuromodulation System - Sham
    • Menlo Park, California
    • +1 more
    Apr 26, 2022

    Narcolepsy Trial in United States (JZP-258)

    Recruiting
    • Narcolepsy
    • Alabaster, Alabama
    • +27 more
    Jul 22, 2022

    Narcolepsy Type 1 (NT 1) Trial in Worldwide (TAK-994, Placebo)

    Terminated
    • Narcolepsy Type 1 (NT 1)
    • Alabaster, Alabama
    • +69 more
    Oct 5, 2022

    Sleep Apnea, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Recruiting
    • Sleep Apnea
    • Obesity
    • Riverside, California
    • +66 more
    Jan 23, 2023

    Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) Trial in Worldwide (TAK-994, Placebo)

    Terminated
    • Narcolepsy Type 1 (NT1)
    • Narcolepsy Type 2 (NT2)
    • Alabaster, Alabama
    • +77 more
    Oct 5, 2022

    Insomnia Disorder Trial in Worldwide (Daridorexant 25 mg, Daridorexant 50 mg, Placebo)

    Completed
    Has Results
    • Insomnia Disorder
    • Daridorexant 25 mg
    • +2 more
    • Anniston, Alabama
    • +80 more
    Mar 24, 2022

    Excessive Daytime Sleepiness, Cataplexy, Narcolepsy Trial in Worldwide (FT218, Placebo)

    Completed
    Has Results
    • Excessive Daytime Sleepiness
    • +2 more
    • Anniston, Alabama
    • +56 more
    Mar 18, 2022

    CBD, Pain, Chronic, Anxiety Trial in Hermitage (CBD)

    Not yet recruiting
    • CBD
    • +4 more
    • Hermitage, Pennsylvania
      Advanced Pain and Rehab Specialists
    Aug 1, 2021

    Insomnia Disorder Trial in Worldwide (Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg)

    Completed
    Has Results
    • Insomnia Disorder
    • Daridorexant 10 mg
    • +3 more
    • Birmingham, Alabama
    • +105 more
    Feb 7, 2022

    Seizures, Lennox Gastaut Syndrome Trial in Bethesda, Hackensack (Carisbamate)

    Recruiting
    • Seizures
    • Lennox Gastaut Syndrome
    • Tampa, Florida
    • +13 more
    Feb 1, 2023

    Myotonic Dystrophy, Type 1 (DM1), Myotonic Dystrophy Trial in United States (ERX-963, Placebo)

    Completed
    Has Results
    • Myotonic Dystrophy, Type 1 (DM1)
    • Myotonic Dystrophy
    • Palo Alto, California
    • +3 more
    Jun 22, 2021

    Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Stiolto Respimat
    • +3 more
    • Mobile, Alabama
    • +89 more
    May 24, 2022

    Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +55 more
    Aug 16, 2022

    Pulmonary Hypertension, COPD Trial in Israel, United States (Inhaled treprostinil solution)

    Terminated
    • Pulmonary Hypertension
    • Chronic Obstructive Pulmonary Disease
    • Inhaled treprostinil solution
    • Birmingham, Alabama
    • +29 more
    Jan 5, 2023

    Prader-Willi Syndrome Trial in United States (Pitolisant oral tablets, Placebo oral tablet)

    Active, not recruiting
    • Prader-Willi Syndrome
    • Pitolisant oral tablets
    • Placebo oral tablet
    • San Diego, California
    • +14 more
    Sep 16, 2022